Abstract
This study investigated the agreement on treatment for attention-deficit/hyperactivity disorder (ADHD) between adults with ADHD and the primary care physicians responsible for their treatment. Adults with ADHD and the primary care physicians responsible for their ADHD treatment completed a survey. The κ-statistic assessed physician–patient agreement on ADHD treatment variables. The eligible sample consisted of 274 patients with confirmed current or previous psychopharmacological treatment for ADHD and the physicians responsible for their treatment. We received 159 questionnaires (58.0 %) with sufficient information from both sources. There were no significant differences between participants and nonparticipants (N = 115) on ADHD sample characteristics. Participants’ mean age was 37.6 years, and 75 (47.2 %) were females. There was high agreement for current pharmacological treatment for ADHD, current and last ADHD drug prescription, treatment for substance use, and misuse of stimulant medication. Agreement for nonpharmacological treatment for ADHD and treatment termination because of the side effects was low. A minority of participants from both sources reported misuse of stimulant medication. There was a moderate correlation between the physicians’ clinical judgment and patients’ self-report on current functioning. The study showed that primary care physicians and their patients agreed on the pharmacological but not the nonpharmacological, treatments given. They also agreed on patients’ current functioning. Physicians and patients reported low levels of misuse of stimulant medication. The results show that pharmacological treatment for adults with ADHD can be safely undertaken by primary care physicians.
Similar content being viewed by others
References
Adams JR, Drake RE (2006) Shared decision-making and evidence-based practice. Community Ment Health J 42(1):87–105
Adler L, Shaw D, Sitt D, Maya E, Morrill I (2009) Issues in the diagnosis and treatment of adult ADHD by primary care physicians. Primary Psychiatry 16(5):57–63
American Psychiatric Association (APA) (2000) Diagnostic and statistical manual of mental disorders text revision, 4th edn. American Psychiatric Association, Washington
Barkley RA, Fischer M, Smallish L, Fletcher K (2006) Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 45(2):192–202
Biederman J, Faraone SV (2005) Attention-deficit hyperactivity disorder. Lancet 366(9481):237–248
Biederman J, Petty CR, Woodworth KY, Lomedico A, Hyder LL, Faraone SV (2012) Adult outcome of attention-deficit/hyperactivity disorder: a controlled 16-year follow-up study. J Clin Psychiatry 73(7):941–950
Braddock CH III, Edwards KA, Hasenberg NM, Laidley TL, Levinson W (1999) Informed decision making in outpatient practice: time to get back to basics. JAMA 282(24):2313–2320
Brinkman WB, Hartl J, Rawe LM, Sucharew H, Britto MT, Epstein JN (2011) Physicians’ shared decision-making behaviors in attention-deficit/hyperactivity disorder care. Arch Pediatr Adolesc Med 165(11):1013–1019
Cooper-Patrick L, Gallo JJ, Gonzales JJ, Vu HT, Powe NR, Nelson C, Ford DE (1999) Race, gender, and partnership in the patient-physician relationship. JAMA 282(6):583–589
Deber RB (1994) Physicians in health care management: 8. The patient-physician partnership: decision making, problem solving and the desire to participate. CMAJ 151(4):423–427
Elia J, Ambrosini PJ, Rapoport JL (1999) Treatment of attention-deficit-hyperactivity disorder. N Engl J Med 340(10):780–788
Fiks AG, Hughes CC, Gafen A, Guevara JP, Barg FK (2011) Contrasting parents’ and pediatricians’ perspectives on shared decision-making in ADHD. Pediatrics 127(1):e188–e196
Goodman DW, Surman CB, Scherer PB, Salinas GD, Brown JJ (2012) Assessment of physician practices in adult attention-deficit/hyperactivity disorder. Prim Care Companion CNS Disord 14(4). pii: PCC11m01312. doi:10.4088/PCC.11m01312
Goss C, Moretti F, Mazzi MA, Del PL, Rimondini M, Zimmermann C (2008) Involving patients in decisions during psychiatric consultations. Br J Psychiatry 193(5):416–421
Hamann J, Leucht S, Kissling W (2003) Shared decision making in psychiatry. Acta Psychiatr Scand 107(6):403–409
Hinnenthal JA, Perwien AR, Sterling KL (2005) A comparison of service use and costs among adults with ADHD and adults with other chronic diseases. Psychiatr Serv 56(12):1593–1599
Hinshaw SP, Scheffler RM, Fulton BD, Aase H, Banaschewski T, Cheng W, Mattos P, Holte A, Levy F, Sadeh A, Sergeant JA, Taylor E, Weiss MD (2011) International variation in treatment procedures for ADHD: social context and recent trends. Psychiatr Serv 62(5):459–464
Hodgkins P, Montejano L, Sasane R, Huse D (2011) Cost of illness and comorbidities in adults diagnosed with attention-deficit/hyperactivity disorder: a retrospective analysis. Prim Care Companion CNS Disord 13(2):e1–e12
Hooper R, Rona RJ, French C, Jones M, Wessely S (2005) Unmet expectations in primary care and the agreement between doctor and patient: a questionnaire study. Health Expect 8(1):26–33
Kaplan SH, Greenfield S, Ware JE Jr (1989) Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care 27(3 Suppl):S110–S127
Kaye S, Darke S (2012) The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care? Addiction 107(3):467–477
Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, Howes MJ, Jin R, Secnik K, Spencer T, Ustun TB, Walters EE (2005) The World Health Organization adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med 35(2):245–256
Kirkwood BR, Sterne JSC (2011) Essential medical statistics Malden, Massachusetts 02148-5020. Blackwell Science Ltd, USA
Klein RG, Mannuzza S, Olazagasti MA, Roizen E, Hutchison JA, Lashua EC, Castellanos FX (2012) Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Arch Gen Psychiatry 69(12):1295–1303
Kovshoff H, Vrijens M, Thompson M, Yardley L, Hodgkins P, Sonuga-Barke EJ, Danckaerts M (2013) What influences clinicians’ decisions about ADHD medication? Initial data from the Influences on Prescribing for ADHD Questionnaire (IPAQ). Eur Child Adolesc Psychiatry [Epub ahead of print]
Kraemer M, Uekermann J, Wiltfang J, Kis B (2010) Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature. Clin Neuropharmacol 33(4):204–206
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174
Lensing MB, Zeiner P, Sandvik L, Opjordsmoen S (2013) Four-year outcome in psychopharmacologically treated adults with ADHD. J Clin Psychiatry 74(1):e87–e93
Leon AC, Olfson M, Portera L, Farber L, Sheehan DV (1997) Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. Int J Psychiatry Med 27(2):93–105
McCarthy S, Wilton L, Murray M, Hodgkins P, Asherson P, Wong IC (2013) Management of adult attention deficit hyperactivity disorder in UK primary care: a survey of general practitioners. Health Qual Life Outcomes 11(1):22
Michielsen M, Semeijn E, Comijs HC, van d, V, Beekman AT, Deeg DJ, Kooij JJ (2012) Prevalence of attention-deficit hyperactivity disorder in older adults in The Netherlands. Br J Psychiatry:201(4):298–305
Mongia M, Hechtman L (2012) Cognitive behavior therapy for adults with attention-deficit/hyperactivity disorder: a review of recent randomized controlled trials. Curr Psychiatry Rep 14(5):561–567
National Institute for Health and Clinical Excellence (2008) Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. Clinical guideline 72. Available at www.nice.org.uk/CG72
Rafalovich A (2005) Exploring clinician uncertainty in the diagnosis and treatment of attention deficit hyperactivity disorder. Sociol Health Illn 27(3):305–323
Rohrbaugh M, Rogers JC (1994) What did the doctor do? When physicians and patients disagree. Arch Fam Med 3(2):125–128
Safren SA (2006) Cognitive-behavioral approaches to ADHD treatment in adulthood. J Clin Psychiatry 67(Suppl):846–850
Shaw K, Wagner I, Eastwood H, Mitchell G (2003) A qualitative study of Australian GPs’ attitudes and practices in the diagnosis and management of attention-deficit/hyperactivity disorder (ADHD). Fam Pract 20(2):129–134
Simon V, Czobor P, Balint S, Meszaros A, Bitter I (2009) Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 194(3):204–211
Sobanski E, Bruggemann D, Alm B, Kern S, Deschner M, Schubert T, Philipsen A, Rietschel M (2007) Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 257(7):371–377
Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJ, Jensen PS, Cantwell DP (1998) Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351(9100):429–433
Taylor E, Dopfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga-Barke E, Steinhausen HC, Zuddas A (2004) European clinical guidelines for hyperkinetic disorder—first upgrade. Eur Child Adolesc Psychiatry 13 Suppl:117–130
Taylor A, Deb S, Unwin G (2011) Scales for the identification of adults with attention deficit hyperactivity disorder (ADHD): a systematic review. Res Dev Disabil 32(3):924–938
Thapar A, Thapar A (2002) Is primary care ready to take on attention deficit hyperactivity disorder? BMC Fam Pract 3:7
The Norwegian Directorate of Health (2007) National guidelines for diagnosis and treatment of AD/HD (IS-1244 Veileder i diagnostikk og behandling av AD/HD) Oslo, Helsedirektoratet
Torgersen T, Gjervan B, Rasmussen K, Vaaler A, Nordahl HM (2013) Prevalence of comorbid substance use disorder during long-term central stimulant treatment in adult ADHD. Atten Defic Hyperact Disord 5(1):59–67
Turgay A, Goodman DW, Asherson P, Lasser RA, Babcock TF, Pucci ML, Barkley R (2012) Lifespan persistence of ADHD: the life transition model and its application. J Clin Psychiatry 73(2):192–201
Waitzkin H (1984) Doctor–patient communication. Clinical implications of social scientific research. JAMA 252(17):2441–2446
Acknowledgments
The study has been made possible by financial support from the Norwegian Directorate of Health, Oslo, Norway.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lensing, M.B., Zeiner, P., Sandvik, L. et al. Adults with ADHD: use and misuse of stimulant medication as reported by patients and their primary care physicians. ADHD Atten Def Hyp Disord 5, 369–376 (2013). https://doi.org/10.1007/s12402-013-0116-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12402-013-0116-8